Man Group plc trimmed its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 20.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 187,378 shares of the company's stock after selling 47,771 shares during the quarter. Man Group plc owned approximately 0.10% of Doximity worth $10,004,000 as of its most recent SEC filing.
Several other large investors have also made changes to their positions in the business. QSV Equity Investors LLC raised its stake in shares of Doximity by 0.3% during the 4th quarter. QSV Equity Investors LLC now owns 60,763 shares of the company's stock worth $3,244,000 after buying an additional 186 shares during the period. Handelsbanken Fonder AB raised its stake in Doximity by 0.7% in the 4th quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company's stock valued at $1,586,000 after purchasing an additional 200 shares during the last quarter. UMB Bank n.a. raised its stake in Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after purchasing an additional 235 shares during the last quarter. Fielder Capital Group LLC raised its stake in Doximity by 4.5% in the 4th quarter. Fielder Capital Group LLC now owns 5,488 shares of the company's stock valued at $293,000 after purchasing an additional 235 shares during the last quarter. Finally, Larson Financial Group LLC raised its stake in Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock valued at $40,000 after purchasing an additional 250 shares during the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at Doximity
In other news, CFO Anna Bryson sold 45,000 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total transaction of $2,575,350.00. Following the completion of the transaction, the chief financial officer now directly owns 357,165 shares in the company, valued at approximately $20,440,552.95. This represents a 11.19% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total value of $113,860.00. Following the transaction, the director now owns 16,618 shares of the company's stock, valued at approximately $946,062.74. This represents a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 37.40% of the company's stock.
Analyst Upgrades and Downgrades
Several research analysts recently commented on DOCS shares. William Blair reissued an "outperform" rating on shares of Doximity in a research note on Friday, May 16th. Raymond James reduced their price objective on Doximity from $83.00 to $65.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. Leerink Partners raised Doximity from a "market perform" rating to an "outperform" rating and increased their price objective for the company from $60.00 to $90.00 in a research note on Friday, February 7th. Wells Fargo & Company reissued an "equal weight" rating on shares of Doximity in a research note on Friday, February 7th. Finally, KeyCorp reduced their price objective on Doximity from $83.00 to $70.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. Eleven investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Doximity currently has an average rating of "Moderate Buy" and an average price target of $61.22.
Check Out Our Latest Stock Analysis on DOCS
Doximity Stock Performance
Shares of NASDAQ DOCS traded down $0.20 during mid-day trading on Friday, reaching $51.06. 1,430,504 shares of the company's stock were exchanged, compared to its average volume of 2,098,689. The firm has a market capitalization of $9.53 billion, a price-to-earnings ratio of 51.06, a PEG ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a 52-week low of $25.00 and a 52-week high of $85.21. The company's 50-day moving average is $56.36 and its 200-day moving average is $58.18.
Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings results on Thursday, May 15th. The company reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. The company's revenue for the quarter was up 17.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.25 earnings per share. As a group, equities analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.
Doximity Company Profile
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Stories

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.